Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cocaine and Dextromethorphan

supplement:

Cocaine

Research Papers that Mention the Interaction

Generally, the DM analogs blocked these effects of cocaine at doses that did not display ataxic and sedative side effects as measured in the inverted screen test.
Pharmacology Biochemistry and Behavior  •  2003  |  View Paper
Dextromethorphan has been reported to decrease the self-administration of several drugs of abuse, including morphine, methamphetamine, cocaine , and nicotine.
Pharmacology Biochemistry and Behavior  •  2003  |  View Paper
Combined treatments (30 min prior to each cocaine administration) with DM dose-dependently decreased locomotor activity for high doses of cocaine (20 mg/kg, i.p./day x 7).
Our results suggest that DM exhibits biphasic effects on the locomotor stimulation induced by cocaine , and that locomotor activities are in parallel with FRA-IR of the striatal complex.
Life sciences  •  2001  |  View Paper
DM decreased the rate … higher doses of cocaine (0.5, 0.25 and 0.125 mg/kg/infusion), and increased the rate of responding for lower doses of cocaine (… 0.03 mg/kg/infusion), suggesting that DM shifted the dose-response curve for cocaine self-administration to the left.
Methods and findings in experimental and clinical pharmacology  •  1997  |  View Paper
DEX pretreatment decreased the stimulating effects induced both by cocaine and amphetamine but no consistent dose-related effects were observed.
The results suggest that DEX may play an important role on the stimulating effects of cocaine and amphetamine and that it may be of some utility in the clinical management of psychostimulants abuse.
Progress in Neuro-Psychopharmacology and Biological Psychiatry  •  1995  |  View Paper